Red Cedar Capital, LLC Evolus, Inc. Transaction History
Red Cedar Capital, LLC
- $158 Million
- Q4 2022
A detailed history of Red Cedar Capital, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Red Cedar Capital, LLC holds 500 shares of EOLS stock, worth $4,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$4,950
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EOLS
# of Institutions
187Shares Held
52MCall Options Held
142KPut Options Held
58.4K-
Tang Capital Management LLC San Diego, CA5MShares$49.5 Million3.9% of portfolio
-
Perceptive Advisors LLC New York, NY4.13MShares$40.9 Million2.08% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$39.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.65MShares$36.1 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$32 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $555M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...